Modern Drug Discovery & Development Summit (M3D) 2016 연사

2016 Modern Drug Discovery & Development Summit (M3D) - 4 Parallel Conferences
(Please select the speaker list you would like to view)
 
3rd Cell and Gene Therapy
Drug Design & Medicinal Chemistry
Non-Coding RNA & RNAi Therapeutics
GPCR in Drug Discovery
 
3rd Cell & Gene Therapy
2016 Featured & Keynote Speakers
 

 

Charles R. Bridges
Vice President, Medical Devices, Cardiovascular Therapeutic Area Expert,
Johnson and Johnson Medical Devices;
Professor of Cardiovascular Surgery,
Mount Sinai School of Medicine

 

Marcus Carr
Vice President Clinical Hematology
Rare Disease Research Unit
Pfizer

 
2016 Distinguished Speaker
Rahul Aras
Co-Founder, President and Chief Executive Officer
Juventas Therapeutics
Aravind Asokan
Interim Director , Gene Therapy Center; Associate Professor of Genetics, School of Medicine
The University of North Carolina at Chapel Hill
Stephen Chang
Vice President, Research & Development
NY Stem Cell Foundation

E. Antonio Chiocca
Harvey W. Cushing Professor of Neurosurgery
Harvard Medical School

Reed Clark
Head of Pharmaceutical Development
Dimension Therapeutics
Diana Colleluori
Senior Director, Quality Control
Bluebird Bio
TJ Cradick
Head of Genome Editing
CRISPR Therapeutics
Anne-Virginie Eggimann
Vice President, Regulatory Science
bluebird bio
Simon Ellison
Head of Commercial
Cell and Gene Therapy Catapult
Guangping Gao
Professor & Director, Horae Gene Therapy Center; Professor of Microbiology & Physiology Systems; Penelope Booth Rockwell Professor in Biomedical Research
University of Massachusetts Medical School
Mehdi Gasmi
Chief Technology Officer
Adverum Biotechnologies, Inc.
Joseph Glorioso
Professor, Microbiology & Molecular Genetics
University of Pittsburgh
Katherine High
Co-Founder, President and Chief Scientific Officer
Spark Therapeutics
Kiyotake Ishikawa
Assistant Professor
Icahn School of Medicine
Noriyuki Kasahara
Professor, Departments of Cell Biology and Pathology; Co-Leader, Viral Oncology Program
University of Miami
Brian Kaspar
Chief Scientific Officer, AveXis;
Principal Investigator
, The Center for Gene Therapy at Nationwide Children's Hospital
Ed Kaye
Chief Executive Officer (Interim) & Chief Medical Officer
Sarepta Therapeutics
Hy Levitsky
Executive Vice President & Chief Scientific Officer
Juno Therapeutics
Sheila Mikhail
Chief Executive Officer & Co-Founder
Bamboo Therapeutics
Michael Naso
Scientific Director, Janssen Biotherapeutics
Janssen R&D
Neil Palmer
President & Principal Consultant
PDCI Market Access
Ian Phillips
Director, Center for Rare Disease Therapies
Keck Graduate Institute of Applied Life Sciences
Hasan Saleheen
R&D Manager, Cell Therapy Technology
GE Healthcare
David Schaffer
Professor, Chemical and Biomolecular Engineering, Bioengineering, Molecular and Cell Biology, and the Helen Wills Neuroscience Institute
University of California at Berkeley
Devyn Smith
Head, Strategy for Pharmatherapeutics
Worldwide R&D, Pfizer
Mark Shearman
Chief Scientific Officer
Applied Genetic Technologies Corporation
Khalid Shah
Associate Professor, Harvard Medical School;
Head, Molecular Neurotherapy & Imaging Laboratory; Director, Stem Cell Therapeutics & Imaging Program, Department of Radiology and Neurology,
Massachusetts General Hospital
Luk Vandenberghe
Assistant Professor in Ophthalmology; Director, Gene Transfer Vector Core
Harvard Medical School
Nora Yang
Director, Portfolio & Project Management, Strategic Operations
National Center for Advancing Translational Sciences (NCATS), National Institutes of Health

 
Drug Design & Medicinal Chemistry
DISTINGUISHED SPEAKERS
Alex Aronov
Director (Research Fellow II), Early Discovery Modeling
Vertex Pharmaceuticals
Haribabu Arthanari
Assistant Professor, Biological Chemistry & Molecular Pharmacology
Harvard Medical School
Tauseef Butt
President
Progenra
Paola Castaldi
Head of Chemical Biology
AstraZeneca
Erin DiMauro
Principal Scientist, Medicinal Chemistry
Amgen
Alexander Dömling
Professor, Dr, Drug Design
University of Groningen
Brenda Eustace
Associate Director, Integrated Biology 
Vertex Pharmaceuticals
Brian Goldman
Research Fellow II
Vertex Pharmaceuticals
Heiner Glombik
Section Head Medicinal Chemistry III, LGCR Chemistry Frankfurt
Sanofi
Ed Griffen
Technical Director 
Medchemica
Doug Johnson
Research Fellow, Neuroscience Medicinal Chemistry and Chemical Biology
Pfizer
Sameer Kawatkar
Senior Scientist, Oncology iMED Business Unit
AstraZeneca
Erin Keaney
Investigator III, Global Discovery Chemistry 
Novartis Institutes for BioMedical Research
Daniel McMasters
Director, Modeling & Informatics
Vertex Pharmaceuticals
Hamid Nasiri
Research Scientist
Evotec AG
Martin Pettersson
Senior Principal Scientist, Neuroscience Medicinal Chemistry
Pfizer
Eric Reese
VP, Sales and Marketing  
SensíQ Technologies Inc.
Vincent Rotello
Professor of Chemistry
University of Massachusetts Amherst
John Schneekloth, Jr.
Principal Investigator, Chemical Biology Laboratory
National Cancer Institute
Woody Sherman
Vice President, Applications Science
Schrödinger
Barry Toure
Investigator III, Experienced Medicinal Chemist, Oncology Research
Novartis Institutes for BioMedical Research
Hua Xu
Principal Scientist, Worldwide Medicinal Chemistry
Pfizer
 
Non-Coding RNA & RNAi Therapeutics
KEYNOTE SPEAKER

Judy Lieberman
Professor, Pediatrics

Harvard Medical School
 

DISTINGUISHED SPEAKERS
Paloma Giangrande
Assistant Professor, Internal Medicine 
University of Iowa
Eli Gilboa
Professor, Microbiology & Immunology
University of Miami
Nagy Habib
Chief of Service for Surgery and Oncology
Imperial College Healthcare NHS Trust
Anders Høgset
Chief Scientific Officer
PCI Biotech
Anastasia Khvorova
Professor, RNA Therapeutics Institute
University of Massachusetts Medical School
David Lewis
Chief Scientific Officer
Arrowhead Pharmaceuticals
Prabodhika Mallikaratchy
Assistant Professor of Chemistry

Lehman College, CUNY
James McNamara
Associate Professor, Internal Medicine
University of Iowa
Kevin Morris
Professor & Associate Director, Center for Gene Therapy

City of Hope
Frank Slack
Director, Institute for RNA Medicine

Harvard Medical School
Tracy Zimmermann
Director, Research
Alnylam Pharmaceuticals
 
GPCR in Drug Discovery

The 2016 speaker list is currently being formed. 

 
Please come back and visit this page for updates.
 

modern-drug-discovery-development-summit-m3d Speakers List